Analysis of folypoly-γ-glutamate synthetase gene expression in human B-precursor ALL and T-lineage ALL cells

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Leclerc, Guy J ^a   Leclerc, Gilles M ^a   Kinser, Ting Ting Hsieh ^a   Barredo, Julio C ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FOLYLPOLYGLUTAMATE SYNTHASE; ISOPROTEIN; LUCIFERASE; MESSENGER RNA; METHOTREXATE; NUCLEAR FACTOR Y; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CCAAT BINDING FACTOR; PEPTIDE SYNTHASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BINDING SITE; CELL LINEAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; E BOX ELEMENT; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRE B LYMPHOCYTE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; REGULATORY MECHANISM; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA PROCESSING; SITE DIRECTED MUTAGENESIS; STEM CELL; TRANSCRIPTION INITIATION; DNA METHYLATION; ENHANCER REGION; GENETICS; LYMPHATIC LEUKEMIA; METABOLISM; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

BINDING SITES; CCAAT-BINDING FACTOR; CELL LINE, TUMOR; DNA METHYLATION; E-BOX ELEMENTS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOID; PEPTIDE SYNTHASES; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 33746165554     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-132     Document Type: Article

References (34)

1. McGuire JJ, Bertino JR: Enzymatic synthesis and function of folylpolyglutamates. Mot Cell Biochem 1981, 38 Spec No(Pt 1):19-48.
2. McGuire JJ, Hsieh P, Coward JK, Bertino JR: Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products. J Biol Chem 1980, 255(12):5776-5788.
3. Moran RG, Colman PD, Rosowsky A, Forsch RA, Chan KK: Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase. Mol Pharmacol 1985, 27(1):156-166.
4. Synold TW, Willits EM, Barredo JC: Role of folylpolygutamate synthetase (FPGS) In antifolate chemotherapy; a biochemical and clinical update. Leuk Lymphoma 1996, 21(1-2):9-15.
5. Baldwin SW, Tse A, Gossett LS, Taylor EC, Rosowsky A, Shih C, Moran RG: Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase. Biochemistry 1991, 30(7):1997-2006.
6. Jackman AL, Taylor GA, Gibson W, Kimbell R, Brown M, Calvert AH, Judson IR, Hughes LR: ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res 1991, 51(20):5579-5586.
7. Rots MG, Willey JC, Jansen G, Van Zantwijk CH, Noordhuis P, DeMuth JP, Kuiper E, Veerman AJ, Pieters R, Peters GJ: mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method. Leukemia 2000, 14(12):2166-2175.
8. Barredo J, Moran RG: Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. Mol Pharmacol 1992, 42(4):687-694.
9. Barredo JC, Synold TW, Laver J, Relling MV, Pui CH, Priest DG, Evans WE: Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood 1994, 84(2):564-569.
10. Egan MG, Sirlin S, Rumberger BG, Garrow TA, Shane B, Sirotnak FM: Rapid decline in folylpolyglutamate synthetase activity and gene expression during maturation of HL-60 cells. Nature of the effect, impact on folate compound polyglutamate pools, and evidence for programmed down-regulation during maturation. J Biol Chem 1995, 270(10):5462-5468.
11. Galpin AJ, Schuetz JD, Masson E, Yanishevski Y, Synold TW, Barredo JC, Pui CH, Relling MV, Evans WE: Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. Mol Pharmacol 1997, 52(1):155-163.
12. Chen L, Qi H, Korenberg J, Garrow TA, Choi YJ, Shane B: Purification and properties of human cytosolic folylpoly-gammaglutamate synthetase and organization, localization, and differential splicing of its gene. J Biol Chem 1996, 271(22):13077-13087.
13. Freemantle SJ, Taylor SM, Krystal G, Moran RG: Upstream organization of and multiple transcripts from the human folylpolygamma-glutamate synthetase gene. J Biol Chem 1995, 270(16):9579-9584.
14. Turner FB, Taylor SM, Moran RG: Expression patterns of the multiple transcripts from the folylpolyglutamate synthetase gene in human leukemias and normal differentiated tissues. J Biol Chem 2000, 275(46):35960-35968.
15. Leclerc GJ, Barredo JC: Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues. Clin Cancer Res 2001, 7(4):942-951.
16. Turner FB, Andreassi 2nd JL, Ferguson J, Titus S, Tse A, Taylor SM, Moran RG: Tissue-specific expression of functional isoforms of mouse folypoly-gamma-glutamae synthetase: a basis for targeting folate antimetabolites. Cancer Res 1999, 59(24):6074-6079.
17. Freemantle SJ, Moran RG: Transcription of the human folylpolygamma-glutamate synthetase gene. J Biol Chem 1997, 272(40):25373-25379.
18. Leclerc GJ, Leclerc GM, Barredo JC: Real-time RT-PCR analysis of mRNA decar. half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines. Cancer Cell Int 2002, 2(1):1.
19. Hanson RD, Connolly NL, Burnett D, Campbell EJ, Senior RM, Ley TJ: Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J Biol Chem 1990, 265(3):1524-1530.
20. Antequera F, Boyes J, Bird A: High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990, 62(3):503-514.
21. Razin A, Cedar H: DNA methylation and gene expression. Microbial Rev 1991, 55(3):451-458.
22. Brown ST, Miranda GA, Galic Z, Hartman IZ Lyon CJ, Aguilera RJ: Regulation of the RAG-I promoter by the NF-Y transcription factor. J Immunol 1997, 158(11):5071-5074.
23. Nomura M, Bartsch S, Nawata H, Omura T, Morohashi K: An E box element is required for the expression of the ad4bp gene, a mammalian homologue of ftz-fl gene, which is essential for adrenal and gonadal development. J Biol Chem 1995, 270(13):7453-7461.
24. Chodosh LA, Baldwin AS, Carthew RW, Sharp PA: Human CCAAT-binding proteins have heterologous subunits. Cell 1988, 53(1):11-24.
25. Zhu QS, Qian B, Levy D: CCAAT/enhancer-binding protein alpha (C/ EBPalpha) activates transcription of the human microsomal epoxide hydrolase gene (EPHXI) through the interaction with DNA-bound NF-Y. J Biol Chem 2004, 279(29):29902-29910.
26. Mantovani R: The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999, 239(1):15-27.
27. Kurioka H, Kishi H, Isshiki H, Tagoh H, Mori K, Kitagawa T, Nagata T, Dohi K, Muraguchi A: Isolation and characterization of a TATA-less promoter for the human RAG-I gene. Mol Immunol 1996, 33(13):1059-1066.
28. Huang DY, Kuo YY, Lai JS, Suzuki Y, Sugano S, Chang ZF: GATA-I and NF-Y cooperate to mediate erythroid-specific transcription of Gfi-IB gene. Nucleic Acids Res 2004, 32(13):3935-3946.
29. Cassel DL, Subudhi SK, Surrey S, McKenzie SE: GATA and NF-Y participate in transcriptional regulation of FcgammaRIIA in megakaryocytic cells. Blood Cells Mol Dis 2000, 26(6):587-597.
30. Liang F, Schaufele F, Gardner DG: Functional interaction of NFY and Sp I is required for type a natriuretic peptide receptor gene transcription. J Biol Chem 2001, 276(2):1516-1522.
31. Cross SH, Bird AP: CpG islands and genes. Curr Opin Genet Dev 1995, 5(3):309-314.
32. Rosowsky A: Chemistry and biological activity of antifolates. Prog Med Chem 1989, 26:1-252.
33. MethPrimer - Design Primers for Methylation PCRs [http://urogene.org/ methprimer/indexl.html]
34. Genomatix, MatInspector program. [http://www.genomatix.de/cgi-bin/tools/ tools/pl]